Cairo – Mubasher: The Arab Drug Company said Monday that it will hold its ordinary general meeting (OGM) on 25 March to discuss the estimated budget for fiscal year 2017/2018.
Furthermore, the OGM will look into the investment budget for the next FY, according to a bourse filing.
The company targets an increase of 347.6% in its profits for FY17/18 to EGP 18.8 million, with an investment budget worth EGP 57.6 million.
The company’s stock was last traded at EGP 11.43.
